Mohini Pathria
Allergy & Immunology · Denver, CONPI 1609296268
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,792 of the $2,192 with a category attached, or 81.8%. 20 manufacturers reported payments, led by Sanofi at 24.8% of the total. Reporting peaked in 2019 at $671 and has fallen 88.9% since, to $75 in 2025. That places this record below the midpoint for allergy & immunology clinicians in CO, where the typical reported total is $2,675.
Across 73 payments — averaging $30.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$544
- AstraZeneca$433
- Phadia US Inc.$261
- Novo Nordisk$150
- Aerin Medical Inc.$139
- GSK$121
- plus $543 from 14 others
What the payments were for
- Grants$40018%
- Food & beverage$1,79282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 3 | $544 |
| AstraZeneca | 20 | $433 |
| Phadia US Inc. | 3 | $261 |
| Novo Nordisk | 11 | $150 |
| Aerin Medical Inc. | 1 | $139 |
| GSK | 5 | $121 |
| AbbVie(2 entities) | 5 | $96 |
| Amarin Pharma, Inc. | 5 | $92 |
| Jazz Pharmaceuticals Inc. | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Lilly USA, LLC | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Genentech USA, Inc. | 1 | $31 |
| Pfizer | 1 | $29 |
| Amgen | 2 | $27 |
| Biocryst US Sales Co., LLC | 1 | $15 |
| Neos Therapeutics, LP | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Novartis | 1 | $12 |
| Alk-abello, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,192 in reported general payments places this provider in the 45th percentile of 89 allergy & immunology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $53,405 |
| Ipratropium Bromide | 43 | $1,639 |
| Epinephrine | 11 | $1,562 |
| Azelastine Hcl | 24 | $860 |
| Fluticasone Propionate | 13 | $173 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Denver
- Rohit KatialDenver$758K
- Eileen WangDenver$274K
- Donald LeungDenver$208K
- Flavia HoyteDenver$70K
- Bruce LanserDenver$34K
- Shaila GogateDenver$21K
- Harold NelsonDenver$14K
- Anna MeyerDenver$9K
- Monica ReddyDenver$6K
- Jessica HuiDenver$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.